Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia

Daniel Cruz; Ronald Karlsberg; Yuzuru Takano; Devandra Vora; Jonathan Tobis

doi:10.1002/ccd.10366

Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia

Catheter Cardiovasc Interv. 2003 Jan;58(1):80-3. doi: 10.1002/ccd.10366.

Authors

Daniel Cruz¹, Ronald Karlsberg, Yuzuru Takano, Devandra Vora, Jonathan Tobis

Affiliation

¹ Department of Cardiology, University of California, Los Angeles, California, USA.

PMID: 12508203
DOI: 10.1002/ccd.10366

Abstract

Subacute stent thrombosis occurred in a patient 34 days after receiving a heparin-coated (HC) stent. The patient developed heparin-induced thrombocytopenia and diffuse thrombosis after the stent was placed. This raises the concern that patients who develop heparin-associated antibodies in the context of a recently placed HC stent may have an increased risk for subacute stent thrombosis.

Publication types

Case Reports

MeSH terms

Acute Disease
Aged
Anticoagulants / administration & dosage
Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Blood Vessel Prosthesis Implantation / adverse effects*
Coated Materials, Biocompatible / adverse effects*
Coronary Angiography
Coronary Artery Disease / diagnostic imaging
Coronary Artery Disease / drug therapy
Coronary Artery Disease / surgery*
Heparin / administration & dosage
Heparin / adverse effects*
Heparin / therapeutic use
Humans
Male
Postoperative Complications*
Stents / adverse effects*
Thrombocytopenia / chemically induced*
Thrombocytopenia / complications*
Thrombocytopenia / diagnostic imaging
Thrombosis / diagnostic imaging
Thrombosis / etiology*
Time Factors

Substances

Anticoagulants
Coated Materials, Biocompatible
Heparin